Frank Wollheim
1 – 80 of 80
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Nanna Svartz (1890-1986) and the discovery of sulfasalazine
(
- Contribution to journal › Article
-
Mark
Response to : 'Correspondence on 'Jan Gösta Waldenströmand rheumatology'' by Moutsopoulos
(
- Contribution to journal › Letter
- 2020
-
Mark
Ralph C Williams Jr and the world of rheumatology : a tribute from Sweden
(
- Contribution to journal › Article
- 2019
-
Mark
Jan Gösta Waldenström and rheumatology
(
- Contribution to journal › Article
-
Mark
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
(
- Contribution to journal › Letter
- 2018
-
Mark
There is a need for new systemic sclerosis subset criteria. A content analytic approach
(
- Contribution to journal › Article
- 2017
-
Mark
Les télocytes, communicateurs dans le stroma sain et lien avec l’inflammation et la fibrose
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Systemic sclerosis
2017) p.165-178(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Nanna Svartz (1890–1986) : Die erste Frau auf einem medizinischen Lehrstuhl in Schweden
(
- Contribution to journal › Article
-
Mark
T-regulatory cells-Triumph of perseverance : The Crafoord Prize for Polyarthritis in 2017
(
- Contribution to journal › Article
- 2016
-
Mark
Diet induced arthritis in pigs: Comment on the Article by Scher et al.
(
- Contribution to journal › Letter
-
Mark
Telocytes, communicators in healthy stroma and relation to inflammation and fibrosis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Universitetsenheterna i reumatologi i Lund och Malmö : Historia med Ido
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
“United we win”, communication is the key for a better future in scleroderma
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Collagenous colitis in systemic sclerosis: an overlooked and treatable complication.
(
- Contribution to journal › Article
-
Mark
International consensus criteria for the diagnosis of Raynaud's phenomenon.
(
- Contribution to journal › Article
- 2013
-
Mark
Messages from the morgue to rheumatology: from Chagas disease to giant cell arteritis.
(
- Contribution to journal › Article
-
Mark
The Crafoord Prize in polyarthritis 2013.
2013) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
The Crafoord Prize in Polyarthritis 2013: Significant discoveries and remaining challenges.
(
- Contribution to journal › Debate/Note/Editorial
- 2011
-
Mark
Advances in CTDs What has been done and what is out there?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Introduction - Microorganisms and the locomotor system.
(
- Contribution to journal › Article
- 2010
-
Mark
Cellular Factor Xiii And Peptidylarginine Deiminase-Catalysed Citrullination In Rheumatoid Arthritis
2010) 30th European Workshop for Rheumatology Research In Annals of the Rheumatic Diseases 69(Suppl. 2).(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease.
(
- Contribution to journal › Article
- 2008
-
Mark
A pain in the knee - is it osteoarthritis?
(
- Contribution to journal › Debate/Note/Editorial
- 2007
-
Mark
Prescription of glucosamine for osteoarthritis: does it work and is it safe?
(
- Contribution to journal › Letter
-
Mark
Treatment of pulmonary fibrosis in systemic sclerosis: Light at the end of the tunnel?
(
- Contribution to journal › Letter
-
Mark
Management of intestinal involvement in systemic sclerosis.
(
- Contribution to journal › Letter
-
Mark
Pathology and animal models of osteoarthritis
2007) p.104-104(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease
(
- Contribution to journal › Article
- 2006
-
Mark
Are occupational risk factors associated with markers of disease severity in patients with systemic scleroderma?
(
- Contribution to journal › Article
-
Mark
The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis
(
- Contribution to journal › Article
- 2005
-
Mark
The 5th annual European league against rheumatism congress in Berlin: A personal perspective
(
- Contribution to journal › Letter
-
Mark
Aspects of science in Scandinavian rheumatology the making of a specialty.
(
- Contribution to journal › Scientific review
-
Mark
Classification of systemic sclerosis. Visions and reality.
(
- Contribution to journal › Scientific review
- 2004
-
Mark
The 4th annual European League Against Rheumatism congress in Lisbon: a personal perspective.
(
- Contribution to journal › Article
-
Mark
Scleroderma renal crisis: the sword of damocles.
(
- Contribution to journal › Letter
-
Mark
A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Is Rituximab a Potential New Therapy in Systemic Sclerosis?: New Evidence Indicates the Presence of CD20-Positive B-lymphocytes in Scleroderma Skin.
(
- Contribution to journal › Letter
- 2003
-
Mark
Genetics and susceptibility to RA - More than HLA
(
- Contribution to journal › Letter
-
Mark
Drug resistance in rheumatology: an area in search of investigators.
(
- Contribution to journal › Article
-
Mark
European collaboration at its best: 23rd European Workshop for Rheumatology Research.
(
- Contribution to journal › Article
-
Mark
Early stages of osteoarthritis: the search for sensitive predictors
(
- Contribution to journal › Article
-
Mark
Die Osteoarthritis (Arthrose) geht uns alle an
(
- Contribution to journal › Letter
-
Mark
Cyclosporin A in rheumatoid arthritis
(
- Contribution to journal › Letter
- 2002
-
Mark
Osteoarthritis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
TNF inhibition as therapy for rheumatoid arthritis.
(
- Contribution to journal › Scientific review
-
Mark
Long term efficacy and safety of cyclosporin versus parenteral old in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension
(
- Contribution to journal › Article
-
Mark
Validecoxib - A viewpoint by Frank A. Wollheim
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
To keep the catch - that is the question: a personal account of the 3rd Annual EULAR Congress, Stockholm.
(
- Contribution to journal › Article
-
Mark
Remicade in der Therapie der rheumatoiden Arthritis und des Morbus Crohn - Kein Grund zur Panik
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
CLASS-studien och dess vetenskapliga redovisning. Etiska regler för publicering åsidosatta
(
- Contribution to journal › Article
- 2001
-
Mark
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
(
- Contribution to journal › Article
-
Mark
Cytokines, metalloproteinase, their inhibitors, and COMP: relation to radiological progression and inflammation in early rheumatoid arthritis
(
- Contribution to journal › Article
- 2000
-
Mark
Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relations to pulmonary involvement
(
- Contribution to journal › Article
- 1997
-
Mark
HLA DRB1* typing and cartilage oligomeric matrix protein as predictors of joint destruction in recent onset rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Cartilage macromolecules and the development of new methods for the assessment of joint disease
(
- Contribution to journal › Article
- 1996
-
Mark
Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor
(
- Contribution to journal › Article
-
Mark
Altered dermatan sulfate proteoglycan synthesis in fibroblast cultures established from skin of patients with systemic sclerosis
(
- Contribution to journal › Article
- 1994
-
Mark
Prevention of joint destruction in antigen-induced arthritis
(
- Contribution to journal › Article
- 1992
-
Mark
Markers of cartilage destruction. In Rheumatoid Arthritis. Recent Research Advances
1992) p.348-362(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 1990
-
Mark
Intraarticular corticosteroid injection into rheumatoid arthritis knees improves extensor muscles strength
(
- Contribution to journal › Article
- 1989
-
Mark
Joint capsular stiffness in knee arthritis. Relationship to intraarticular volume, hydrostatic pressures, and extensor muscle function
(
- Contribution to journal › Article
-
Mark
Synovial fluid acidosis correlates with radiological joint destruction in rheumatoid arthritis knee joints
(
- Contribution to journal › Article
-
Mark
Direct assessment of synovial blood flow and its relation to induced hydrostatic pressure changes
(
- Contribution to journal › Article
- 1988
-
Mark
Measurement of synovial fluid volume using albumin dilution upon intraarticular saline injection
(
- Contribution to journal › Article
-
Mark
Mononuclear cells recovered from inflammatory synovial membrane using fine-needle biopsy
(
- Contribution to journal › Article
-
Mark
Human arthritic synovial fluid influences proteoglycan biosynthesis and degradation in organ culture of bovine nasal cartilage.
(
- Contribution to journal › Article
-
Mark
Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.
(
- Contribution to journal › Article
-
Mark
Radiographic assessment in relation to clinical and biochemical variables in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related.
(
- Contribution to journal › Article
- 1987
-
Mark
Hyaluronidase treatment of synovial fluid affects the recovery of mononuclear cells and their in vitro immunoglobulin synthesis
(
- Contribution to journal › Article
-
Mark
Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Relation to systemic treatment.
(
- Contribution to journal › Article
-
Mark
Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis?
(
- Contribution to journal › Article
-
Mark
Analysis of homogentisic acid in body fluids by high-performance liquid chromatography
(
- Contribution to journal › Article
- 1986
-
Mark
Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid.
(
- Contribution to journal › Article
- 1985
-
Mark
Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis.
(
- Contribution to journal › Article
- 1984
-
Mark
Acute alveolitis and sulphasalazine in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Factors related to the progression of joint destruction in rheumatoid arthritis.
(
- Contribution to journal › Article
- 1982
-
Mark
Preleukemic syndrome simulating SLE
(
- Contribution to journal › Article
- 1980
-
Mark
Plasma levels of beta-2 microglobulin in rheumatoid arthritis.
(
- Contribution to journal › Article